Evaluation of the Causes and Disease Processes of Chronic Lung Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 7 - 90 |
| Updated: | 4/5/2019 |
| Start Date: | March 11, 1982 |
| Contact: | Tania R Machado |
| Email: | tania.machado@nih.gov |
| Phone: | (301) 496-3632 |
Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)
Chronic lung diseases are disorders associated with abnormalities in any of the structures
involved in the process of breathing and bringing oxygen into the lungs and blood. This
includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the
tissue covering the lungs (pleura).
The purpose of this research study is to evaluate patients referred to the Cardiovascular and
Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to;
1.Develop a better understanding of the causes and disease processes involved in
disorders of the lungs
2.Identify patients eligible to participate in other P-CCMB research studies
involved in the process of breathing and bringing oxygen into the lungs and blood. This
includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the
tissue covering the lungs (pleura).
The purpose of this research study is to evaluate patients referred to the Cardiovascular and
Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to;
1.
disorders of the lungs
2.
The chronic lung diseases are those disorders associated with functional and/or structural
derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or
mediastinum. The purpose of this project is to permit the comprehensive evaluation of
patients referred to the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and
Blood Institute (NHLBI) in order to: (1) develop an understanding of the etiology and
pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates
for other NHLBI protocols. Testing and procedures will only be performed when medically
indicated for the purposes of making a diagnosis or obtaining information likely to be useful
in the management of the subjects' disease or condition.
derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or
mediastinum. The purpose of this project is to permit the comprehensive evaluation of
patients referred to the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and
Blood Institute (NHLBI) in order to: (1) develop an understanding of the etiology and
pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates
for other NHLBI protocols. Testing and procedures will only be performed when medically
indicated for the purposes of making a diagnosis or obtaining information likely to be useful
in the management of the subjects' disease or condition.
- INCLUSION CRITERIA:
Symptoms consistent with pulmonary disease.
May have family history of lung disease.
Patients with diseases of organs with known association with lung disease.
Ranging in age from 7 to 90 years old.
EXCLUSION CRITERIA:
Persons with no clinical evidence of lung disease.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials
